Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.57 |
| ▸ | NMT2 | O60551 | 2/20 | 0.49 |
| ▸ | NMT1 | P30419 | 2/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.49 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | FURIN | P09958 | 3/20 | 0.47 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29417579 | 0.97 | CTSL (0.58) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL3121566 | 0.96 | SLC6A5 (0.60) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL1032838 | 0.96 | SLC6A5 (0.62) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL28627441 | 0.96 | SLC6A5 (0.62) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL443317 | 0.91 | SLC6A5 (0.66) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL445569 | 0.91 | SLC6A5 (0.66) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL23227556 | 0.91 | CTSL (0.56) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL5604836 | 0.90 | SLC6A5 (0.65) | CTSLSLC6A5NMT2NMT1NOD1 | |
| SCHEMBL29520919 | 0.89 | SLC6A5 (0.64) | CTSLSLC6A5NMT2NMT1NOD1 | |
| Acetic Acid SCHEMBL25220206 | 0.89 | SLC6A5 (0.64) | CTSLSLC6A5NMT2NMT1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2022-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | CTSL 1100/4885SLC6A5 2755/4885NMT2 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.